Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Theranostics Companies

Theranostics is an emerging field in medicine that combines diagnostics and therapeutics to create personalized treatment plans. It involves identifying specific biomarkers in a patient, diagnosing a condition, and then tailoring a treatment based on the diagnostic results.

Theranostics Key Comapnies

Latest Theranostics Companies Update:

Roche received FDA approval for Lumicist™ (flucicloviol F 18), a radiopharmaceutical for imaging prostate cancer recurrence. This expands their theranostics portfolio and provides a valuable tool for accurate diagnosis and treatment planning.

Novartis launched Lutathera™ (lutatetium Lu 177 vipivotide tetraxetan) in Europe for the treatment of neuroendocrine tumors. This marks a significant step in personalized medicine for patients with these rare cancers.

AstraZeneca signed a collaboration agreement with ImaginAb Inc. to develop novel radiopharmaceuticals for targeted alpha therapy. This partnership combines AstraZeneca's expertise in oncology with ImaginAb's innovative Alphamab platform.

GE Healthcare and Minerva Imaging entered into a strategic partnership to accelerate the commercial launch of targeted radionuclide therapies. This collaboration leverages GE Healthcare's imaging technologies and Minerva's expertise in radiopharmaceutical development.

Blue Earth Diagnostics and PKM Therapeutics are focusing on developing next-generation theranostic agents with improved targeting, efficacy, and theranostic capabilities.

List of Theranostics Key companies in the market

Thermo Fisher Scientific Inc.

Beckman Coulter, Inc.

Hoffmann-La Roche Ltd

Focus Diagnostics

Illumina, Inc.

Agilent Technologies, Inc.

QIAGEN

Abbott Laboratories

Myriad Genetics, Inc.

Foundation Medicine, Inc.

AmeriPath, Inc.

Theranostics Market Highlights:

Theranostics Market Size

Theranostics Market Trends

Theranostics Market Analysis

Theranostics Market Share

Theranostics Market Highlights:

Theranostics Market Trends

Theranostics Market Analysis

Theranostics Market Share

Theranostics Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.